| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/25/2007 | US7312317 P2Y4 antibodies |
| 12/25/2007 | US7312316 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides |
| 12/25/2007 | US7312315 PRO9742 antibodies |
| 12/25/2007 | US7312314 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 12/25/2007 | US7312313 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 12/25/2007 | US7312312 PRO6242 polypeptides |
| 12/25/2007 | US7312309 For release of tumor necrosis and or cellular differentation/proliferation of chrondrocytes by contacting blood w/polypeptides; cancer diagnosis |
| 12/25/2007 | US7312308 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 12/25/2007 | US7312303 Anti-PRO4980 antibodies |
| 12/25/2007 | US7312192 For treating diseases including diabetes |
| 12/25/2007 | US7312089 Contacting biological sample with antibodies having specific binding affinity for erytrhopoetin receptor(EpoR), detecting presence, absence, or amount of EpoR by identifying the human blood progenitor cells having antibody bound thereto |
| 12/25/2007 | US7312086 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders |
| 12/25/2007 | US7312065 Virulent isolate of Lawsonia intracellularis; protecting against and diagnosing porcine proliferative enteropathy |
| 12/25/2007 | US7312050 Nucleic acids encoding interphotoreceptor matrix proteins |
| 12/25/2007 | US7312024 Anticancer agents; administering interleukin polypeptide |
| 12/25/2007 | US7311921 Effective against FIVDix, FIVUK8, FIVBang, FIVAom1, FIVAom2, FIVPet, and FIVShi. |
| 12/25/2007 | US7311920 Virus coat protein/receptor chimeras and methods of use |
| 12/25/2007 | US7311917 Membrane proteins; fusion proteins; vaccines; kits |
| 12/25/2007 | US7311916 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry |
| 12/25/2007 | US7311913 humanized monoclonal antibodies against human antihemophilic factor, used as antithrombotic agents, for treatment of strokes, ischemia, angina, necrosis, thrombosis, anemia, urogental disorders, thrombocytopenia or restenosis; cardiovascular disorders |
| 12/25/2007 | US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy |
| 12/25/2007 | US7311911 Methods for inhibiting angiogenesis |
| 12/25/2007 | US7311910 Inhibiting interaction of CTLA4(Cytotoxic T-Lymphocyte Antigen 4)positive T cells with B7-1 or B7-2 positive cells by contacting with an antibody or antibody fragment which recognizes and binds an extracellular domain; tissue transplant rejection; graft versus host disease |
| 12/25/2007 | US7311909 PRO4348 antibodies |
| 12/25/2007 | US7311906 Administering anti-TK1 antibody conjugated to cytotoxic agent consisting of pokeweed antiviral protein (PAP), ricin, abrin, gelonin, saporin, and alpha-sarcin; detecting and diagnosing viral infections |
| 12/21/2007 | WO2007147122A2 Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds |
| 12/21/2007 | WO2007146857A2 Anti- mcp-1 antibodies expressed in lemna, compositions, methods and uses |
| 12/21/2007 | WO2007146847A2 Glycosylation engineered antibody therapy |
| 12/21/2007 | WO2007146401A2 Denatured collagen peptides and uses thereof |
| 12/21/2007 | WO2007146172A2 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 12/21/2007 | WO2007145362A1 Glyceroglycolipid antigen of mycoplasma pneumoniae |
| 12/21/2007 | WO2007145318A1 Sparc-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
| 12/21/2007 | WO2007145192A1 Collagen type iv-like immunoreactive peptide |
| 12/21/2007 | WO2007144730A1 Compositions and methods for delivering anti-activated ras antibodies into cells |
| 12/21/2007 | WO2007144046A2 Agent for the treatment of malignant diseases |
| 12/21/2007 | WO2007143819A1 Nitrogen limitation adaptibility gene and protein and modulation thereof |
| 12/21/2007 | WO2007126655A8 Eggs having increased antibody titer and methods for making same |
| 12/21/2007 | WO2007117996A3 Methods for treating conditions associated with masp-2 dependent complement activation |
| 12/21/2007 | WO2007089871A8 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| 12/21/2007 | WO2007070252A3 Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same |
| 12/21/2007 | WO2007056540A3 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy |
| 12/21/2007 | WO2007042261A3 Compositions comprising cross-species-specific antibodies and uses thereof |
| 12/21/2007 | WO2006135793A3 Protein engineering with analogous contact environments |
| 12/21/2007 | WO2006116475A3 Immunostimulatory compositions |
| 12/21/2007 | WO2006037383A8 Piscirickettsia salmonis antigens and use thereof |
| 12/21/2007 | WO2005116270A3 Influenza virus vaccine composition and method of use |
| 12/21/2007 | WO2005044012A3 Method for the decontamination of biological tissue |
| 12/21/2007 | WO2005023193A3 Methods of treating endometriosis |
| 12/21/2007 | WO2003064613A3 Amidases, nucleic acids encoding them and methods for making and using them |
| 12/21/2007 | CA2690709A1 Glyceroglycolipid antigen of mycoplasma pneumoniae |
| 12/21/2007 | CA2657948A1 Denatured collagen peptides and uses thereof |
| 12/21/2007 | CA2655372A1 Il-17 and il-23 antagonists and methods of using the same |
| 12/21/2007 | CA2655361A1 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same |
| 12/21/2007 | CA2654584A1 Extending survival of cancer patients with elevated levels of egf or tgf-alpha |
| 12/21/2007 | CA2654563A1 Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
| 12/21/2007 | CA2654317A1 Single-chain multivalent binding proteins with effector function |
| 12/21/2007 | CA2652703A1 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 12/21/2007 | CA2651962A1 Anthrax compositions and methods of use and production |
| 12/21/2007 | CA2650127A1 Nitrogen limitation adaptibility gene and protein and modulation thereof |
| 12/20/2007 | WO2008127261A1 Bst2 inhibitor |
| 12/20/2007 | US20070293450 Identification of ses-3 and the uses of same |
| 12/20/2007 | US20070293438 Antibody specifically binding to sulfonylated protein protein and method for producing the same |
| 12/20/2007 | US20070293425 Mutein of a Bone Morphogenetic Protein and Use Thereof |
| 12/20/2007 | US20070292966 Assessment of Skeletal Growth Using Measurements of Nt-Cnp Peptides |
| 12/20/2007 | US20070292947 Novgel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 12/20/2007 | US20070292944 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulators of taste preception; artificial sweeteners and enhancement of food flavors |
| 12/20/2007 | US20070292936 Binding polypeptides with optimized scaffolds |
| 12/20/2007 | US20070292922 Regulated expression of recombinant proteins from adeno-associated viral vectors |
| 12/20/2007 | US20070292887 Immunohistochemical Methods |
| 12/20/2007 | US20070292885 Human cdnas and proteins and uses thereof |
| 12/20/2007 | US20070292847 nucleic acid molecule encoding a protein that hydrolyzes cyclic adenosine mono-phosphate (cAMP); leishmaniasis |
| 12/20/2007 | US20070292444 Peptides for treatment and diagnosis of bone diseases |
| 12/20/2007 | US20070292443 Polypeptides with multifunction |
| 12/20/2007 | US20070292442 Using cation exchange to separate host cell protein (HCP) form preferential antibody on chromatographic column |
| 12/20/2007 | US20070292441 Tumor Specific Antibody |
| 12/20/2007 | US20070292440 CD154 blockade therapy for pancreatic islet tissue transplantation |
| 12/20/2007 | US20070292439 B cell-related cancers and solid tumors, and diseases or disorders that have an autoimmune and/or inflammatory component, including organ and tissue transplant rejection |
| 12/20/2007 | US20070292438 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 12/20/2007 | US20070292436 Immunogenic proteoliposomes, and uses thereof |
| 12/20/2007 | US20070292434 Blocking tetramerization of leptin receptor with anti-fibronectin III domain antibody, inhibiting leptin induced signalling; binding of a compound to non-leptin-binding domains of extracellular part of leptin receptor can block leptin-induced signaling without blocking leptin binding; weight modulation |
| 12/20/2007 | US20070292431 4-1Bb Receptors are Expressed on Regulatory T-Cells |
| 12/20/2007 | US20070292428 Antibodies Against Cancer Produced Using Masked Cancer Cells as Immunogen |
| 12/20/2007 | US20070292427 Substantially pure steroidogenesis inducing peptide and uses thereof |
| 12/20/2007 | US20070292426 Methods and compositions based on Shiga toxin type 1 protein |
| 12/20/2007 | US20070292425 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof |
| 12/20/2007 | US20070292424 Novel human eosinophil-derived basic protein |
| 12/20/2007 | US20070292420 For diagnosing or treating rheumatoid arthritis, osteoarthritis, osteolysis, aseptic loosening of orthopedic implants, lupus, type 2 diabetes, COPD, and renal cell carcinoma |
| 12/20/2007 | US20070292419 Treatment with anti-erbb2 antibodies |
| 12/20/2007 | US20070292417 Chimeric allgraft tolerance induction, monitoring and maintenance |
| 12/20/2007 | US20070292416 De-Immunized Anti-Cd3 Antibody |
| 12/20/2007 | US20070292415 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/20/2007 | US20070292411 Antibodies That Immunospecifically Bind to TRAIL Receptors |
| 12/20/2007 | US20070292410 Using mutant superoxide dismutase 1 (SOD1) as tool in diagnosis, prevention and treatment of nervous system disorders |
| 12/20/2007 | US20070292409 Identifying modulators of G protein-coupled receptor kinase 2 (GRK2); treatment and prevention of type 2 diabetes mellitus and insulin resistance in humans |
| 12/20/2007 | US20070292390 Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies |
| 12/20/2007 | US20070292348 Treating Wnt signaling-related diseases, for detecting mammary basal-like cells, for diagnosing basal-like breast cancer, and for inhibiting proliferation of a tumor expressing LRP6 |
| 12/20/2007 | US20070292347 Peptides Associated with Hla-Dr Mhc Clas II Molecules Involved in Autoimmune Diseases |
| 12/20/2007 | US20070292346 Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk |
| 12/20/2007 | CA2635467A1 Bst2 inhibitor |
| 12/19/2007 | EP1867720A2 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |